Solactive Future Pharmaceutical Europe Index
The Solactive Future Pharmaceutical Europe Index tracks the performance of the 15 largest European pharmaceutical companies by market capitalization, weighted according to their “Innovation Value”, thereby allocating more weight to companies investing a higher percentage of their total assets in research and development.
Master Data
| ISIN: | DE000SLA5EB2 |
| Bloomberg Ticker: | SOLFUPHA Index |
| WKN: | SLA5EB |
Current Quotes
| Last quote (16 Apr 2024): | 589.47 |
| Day range: | 588.45 / 594.93 |
| Change abs./rel.: | -6.51 / -1.09% |
| Year range: | 533.32 / 622.83 |
| Name | Number of shares |
|---|---|
| GENMAB A/S | 0.259584 |
| NOVARTIS AG | 0.339027 |
| ROCHE HOLDING AG | 0.293544 |
| GSK PLC | 1.916861 |
| SANOFI SA | 0.153612 |
| ASTRAZENECA PLC | 0.495515 |
| SANDOZ GROUP AG | 0.066188 |
| RECORDATI SPA | 0.686813 |
| IPSEN SA | 0.262222 |
| MERCK KGAA | 0.090014 |
| NOVO NORDISK A/S | 0.340884 |
| SARTORIUS AG PREF | 0.04236 |
| LONZA GROUP AG | 0.029088 |
| UCB SA | 0.733456 |
| BAYER AG | 0.301095 |
| ARGENX SE | 0.187697 |